251 related articles for article (PubMed ID: 10609553)
1. High-affinity stereoselective reduction of the enantiomers of ketotifen and of ketonic nortriptyline metabolites by aldo-keto reductases from human liver.
Breyer-Pfaff U; Nill K
Biochem Pharmacol; 2000 Feb; 59(3):249-60. PubMed ID: 10609553
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective high-affinity reduction of ketonic nortriptyline metabolites and of ketotifen by aldo-keto reductases from human liver.
Breyer-Pfaff U; Nill K
Adv Exp Med Biol; 1999; 463():473-80. PubMed ID: 10352721
[No Abstract] [Full Text] [Related]
3. Stereoselective reversible ketone formation from 10-hydroxylated nortriptyline metabolites in human liver.
Breyer-Pfaff U; Nill K
Xenobiotica; 1995 Dec; 25(12):1311-25. PubMed ID: 8719907
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of oxidoreductases-catalyzing carbonyl reduction of the tobacco-specific nitrosamine 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in human liver cytosol.
Atalla A; Breyer-Pfaff U; Maser E
Xenobiotica; 2000 Aug; 30(8):755-69. PubMed ID: 11037109
[TBL] [Abstract][Full Text] [Related]
5. Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members.
O'connor T; Ireland LS; Harrison DJ; Hayes JD
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):487-504. PubMed ID: 10510318
[TBL] [Abstract][Full Text] [Related]
6. Aldo-keto reductases (AKR) from the AKR1C subfamily catalyze the carbonyl reduction of the novel anticancer drug oracin in man.
Wsol V; Szotakova B; Martin HJ; Maser E
Toxicology; 2007 Sep; 238(2-3):111-8. PubMed ID: 17618725
[TBL] [Abstract][Full Text] [Related]
7. Reduction of drug ketones by dihydrodiol dehydrogenases, carbonyl reductase and aldehyde reductase of human liver.
Ohara H; Miyabe Y; Deyashiki Y; Matsuura K; Hara A
Biochem Pharmacol; 1995 Jul; 50(2):221-7. PubMed ID: 7632166
[TBL] [Abstract][Full Text] [Related]
8. Purification and characterization of two major forms of naloxone reductase from rabbit liver cytosol, new members of aldo-keto reductase superfamily.
Yamano S; Ichinose F; Todaka T; Toki S
Biol Pharm Bull; 1999 Oct; 22(10):1038-46. PubMed ID: 10549852
[TBL] [Abstract][Full Text] [Related]
9. Carbonyl reduction of warfarin: Identification and characterization of human warfarin reductases.
Malátková P; Sokolová S; Chocholoušová Havlíková L; Wsól V
Biochem Pharmacol; 2016 Jun; 109():83-90. PubMed ID: 27055738
[TBL] [Abstract][Full Text] [Related]
10. Dihydrodiol dehydrogenase activities of rabbit liver are associated with hydroxysteroid dehydrogenases and aldo-keto reductases.
Klein J; Thomas H; Post K; Wörner W; Oesch F
Eur J Biochem; 1992 May; 205(3):1155-62. PubMed ID: 1576998
[TBL] [Abstract][Full Text] [Related]
11. Activation of polycyclic aromatic hydrocarbon trans-dihydrodiol proximate carcinogens by human aldo-keto reductase (AKR1C) enzymes and their functional overexpression in human lung carcinoma (A549) cells.
Palackal NT; Lee SH; Harvey RG; Blair IA; Penning TM
J Biol Chem; 2002 Jul; 277(27):24799-808. PubMed ID: 11978787
[TBL] [Abstract][Full Text] [Related]
12. Enantioselectivity of carbonyl reduction of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone by tissue fractions from human and rat and by enzymes isolated from human liver.
Breyer-Pfaff U; Martin HJ; Ernst M; Maser E
Drug Metab Dispos; 2004 Sep; 32(9):915-22. PubMed ID: 15319331
[TBL] [Abstract][Full Text] [Related]
13. Cloning and characterization of four rabbit aldo-keto reductases featuring broad substrate specificity for xenobiotic and endogenous carbonyl compounds: relationship with multiple forms of drug ketone reductases.
Endo S; Matsunaga T; Arai Y; Ikari A; Tajima K; El-Kabbani O; Yamano S; Hara A; Kitade Y
Drug Metab Dispos; 2014 Apr; 42(4):803-12. PubMed ID: 24510382
[TBL] [Abstract][Full Text] [Related]
14. Enzymology of a carbonyl reduction clearance pathway for the HIV integrase inhibitor, S-1360: role of human liver cytosolic aldo-keto reductases.
Rosemond MJ; St John-Williams L; Yamaguchi T; Fujishita T; Walsh JS
Chem Biol Interact; 2004 Mar; 147(2):129-39. PubMed ID: 15013815
[TBL] [Abstract][Full Text] [Related]
15. Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family.
Matsumoto K; Endo S; Ishikura S; Matsunaga T; Tajima K; El-Kabbani O; Hara A
Biol Pharm Bull; 2006 Mar; 29(3):539-42. PubMed ID: 16508162
[TBL] [Abstract][Full Text] [Related]
16. Comparative anatomy of the aldo-keto reductase superfamily.
Jez JM; Bennett MJ; Schlegel BP; Lewis M; Penning TM
Biochem J; 1997 Sep; 326 ( Pt 3)(Pt 3):625-36. PubMed ID: 9307009
[TBL] [Abstract][Full Text] [Related]
17. The aldo-keto reductases (AKRs): Overview.
Penning TM
Chem Biol Interact; 2015 Jun; 234():236-46. PubMed ID: 25304492
[TBL] [Abstract][Full Text] [Related]
18. Lens aldo-keto reductase of Camelus dromedarius: purification and properties.
Del Corso A; Barsacchi D; Osman AM; Mohamed AS; Tozzi MG; Camici M; Mura U
Biochim Biophys Acta; 1989 Oct; 993(1):116-20. PubMed ID: 2679888
[TBL] [Abstract][Full Text] [Related]
19. In vitro metabolism and identification of human enzymes involved in the metabolism of methylnaltrexone.
Tong Z; Chandrasekaran A; Li H; Rotshteyn Y; Erve JC; Demaio W; Talaat R; Hultin T; Scatina J
Drug Metab Dispos; 2010 May; 38(5):801-7. PubMed ID: 20173089
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin-E2 9-reductase from corpus luteum of pseudopregnant rabbit is a member of the aldo-keto reductase superfamily featuring 20 alpha-hydroxysteroid dehydrogenase activity.
Wintergalen N; Thole HH; Galla HJ; Schlegel W
Eur J Biochem; 1995 Nov; 234(1):264-70. PubMed ID: 8529651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
